PT  - JOURNAL ARTICLE
AU  - Wissam Saliba
AU  - Boutros El-Haddad
TI  - Secondary Hyperparathyroidism: Pathophysiology and Treatment
AID  - 10.3122/jabfm.2009.05.090026
DP  - 2009 Sep 01
TA  - The Journal of the American Board of Family Medicine
PG  - 574--581
VI  - 22
IP  - 5
4099  - http://www.jabfm.org/content/22/5/574.short
4100  - http://www.jabfm.org/content/22/5/574.full
SO  - J Am Board Fam Med2009 Sep 01; 22
AB  - Secondary hyperparathyroidism is a frequently encountered problem in the management of patients with chronic kidney disease (CKD). Its pathophysiology is mainly due to hyperphosphatemia and vitamin D deficiency and resistance. This condition has a high impact on the mortality and morbidity of dialysis patients. Early diagnosis of secondary hyperparathyroidism is crucial in the management of patients with CKD. The treatment remains a challenge for patients and their clinicians. It should include a combination of dietary phosphorus restriction, phosphate binders, vitamin D analogues, and calcimimetics.